Dose Proportionality Study With BAY94-8862 IR (Immediate Release) Tablets

Inclusion Criteria: * Healthy male subject * Age: 18 to 46 years (inclusive) at the first screening examination * Ethnicity: White * Body mass index (BMI): \>= 18 and \<= 29.9 kg / m² Exclusion Criteria: * Clinically relevant findings in the ECG (electrocardiogram) such as a second- or third-degree AV block, prolongation of the QRS complex over 120 msec * Systolic blood pressure below 100 or above 140 mmHg * Diastolic blood pressure below 50 or above 90 mmHg * Heart rate below 50 or above 95 beats/ min * Positive results for hepatitis B virus surface antigen (HBsAg), hepatitis C virus antibodies (anti-HCV), human immune deficiency virus antibodies (anti-HIV 1+2) * Participation in another clinical study during the preceding 3 months (Last Treatment from previous study to First Treatment of new study)